Following Reverse Merger with Xtrana, Alpha Innotech Trades on OTCBB

NEW YORK, Oct. 10 (GenomeWeb News) - Alpha Innotech and Xtrana have closed a reverse merger, the companies said last week.

The merged company changed its name to Alpha Innotech and began trading on the NASD over-the-counter bulletin board under the new name last week, following a one-for-ten reverse stock split.

Alpha Innotech shareholders and Xtrana stockholders approved the merger earlier this month. All outstanding capital stock of Alpha Innotech, which was privately held prior to the merger, was converted into the right to receive shares of Xtrana common stock.

Alpha Innotech, based in San Leandro, Calif., provides digital imaging and detection system for life science research. The company combines instruments, reagents, and bioinformatics software to offer integrated technology platforms for electrophoresis, functional genomics, proteomics, and cell analysis. The company had $10.5 million in revenues last year.